# DiaMedica Therapeutics Inc.: Form 8-K, filed May 19, 2022

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2022-05-19
- Accepted by EDGAR: May 19, 2022, 17:00 ET
- Period: 2022-05-18
- Accession: 0001437749-22-013082
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774922013082/dmtp20220518_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774922013082/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774922013082/dmtp20220518_8k.htm

Filed May 19, 2022.
Source: SEC EDGAR, the filing index for accession 0001437749-22-013082. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.